-
FDA Approves New, Stronger Warnings For ADHD Drugs
Sudden Deaths, Strokes, And Heart Attacks In Adults At Usual Doses Several drugs to treat attention deficit hyperactivity disorder (ADHD) — including GlaxoSmithKline (GSK) Plc’s Dexedrine, Novartis AG’s Ritalin, Johnson & Johnson’s Concerta, and…
-
Vioxx: Judge Higbee Sets 39 Vioxx Lawsuits For 2007 Trial Dates
Consolidated Trials For Groups Of Individual Cases Is Possibility By way of The Philadelphia Inquirer we learned on July 28, 2006 that Bloomberg News is reporting 8,800 Vioxx lawsuits have been filed against Merck…
-
Anti-Epileptic Drugs Associated With Birth Defects And Fetal Death
Study Looks At Depakote, Dilantin, Tegretol, And Lamictal An August 8, 2006 article in the Los Angeles Times (LA Times) reports about a recent study involving four popular epilepsy drugs which found that one…
-
Natrecor: An Example Of How Drug Companies Might Influence Doctors
"Off-label" Prescribing Is At Center Of Ongoing Natrecor Controversy A recent article of interest is "The Rise And Fall Of Natrecor For Congestive Heart Failure: Implications For Drug Policy", by Aaron S. Kesselheim, Michael…
-
Ketek Allegedly “More Toxic Than Most Other Drugs”
Dr. David Graham At FDA Wants An "Immediate Withdrawal" Of Ketek On the morning of July 19, 2006 a National Public Radio (NPR) news piece about Ketek brought our attention back to this increasingly…